An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
NCT00635427
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease, Type 1
Interventions
BIOLOGICAL:
VPRIV®
Sponsor
Shire